271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

273 trials found

diseases per page:

Showing 1 to 10 of 273 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL
2	NCT05212051 (ClinicalTrials.gov)	December 10, 2021	30/11/2021	Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients Wi ...	A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Prelimin ...	Active Ankylosing Spondylitis	Biological: JS005;Biological: Placebo	Shanghai Junshi Bioscience Co., Ltd.	Sponsor GmbH	Recruiting	18 Years	65 Years	All	120	Phase 2	China
3	NCT05094128 (ClinicalTrials.gov)	November 22, 2021	20/10/2021	A Study to Assess Disease Activity in Adult Participants With Ankylosing Spondylitis Who Receive Upa ...	Effectiveness of Upadacitinib in Patients With Ankylosing Spondylitis Suffering From Typical Disease ...	Radiographic Axial Spondylarthritis (r-axSpA)	Drug: Upadacitinib	AbbVie	NULL	Recruiting	18 Years	N/A	All	352		Germany
4	NCT04934059 (ClinicalTrials.gov)	July 1, 2021	8/6/2021	Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).	A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy ...	Ankylosing Spondylitis	Drug: Yuxuebi tablet;Drug: Placebo tablet	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	NULL	Not yet recruiting	18 Years	65 Years	All	60	Phase 4	China
5	NCT04840485 (ClinicalTrials.gov)	June 9, 2021	7/4/2021	Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis	A Randomized, Double-blind, Multicenter, Placebo-controlled, Phase II/III Adaptive Study of SHR-1314 ...	Ankylosing Spondylitis	Drug: SHR-1314;Drug: Placebo	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	NULL	Recruiting	18 Years	N/A	All	529	Phase 2/Phase 3	China
6	NCT04885751 (ClinicalTrials.gov)	June 1, 2021	26/4/2021	Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy	Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients Wi ...	Rheumatoid Arthritis;Osteoarthritis;Ankylosing Spondylitis;Other Musculoskeletal Disorder;Gastric Ul ...	Drug: Eupatilin;Drug: Rebamipide	Seoul National University Boramae Hospital	Dong-A ST Co., Ltd.	Not yet recruiting	19 Years	70 Years	All	50	Phase 4	NULL
7	ChiCTR2100044377	2021-04-01	2021-03-17	Study on the curative effect of spectrum therapy instrument in ankylosing spondylitis	Study on the curative effect of spectrum therapy instrument in ankylosing spondylitis	Ankylosing spondylitis	AS Spectrum Treatment Group:None;	The First Affiliated Hospital of Suzhou University	NULL	Recruiting	19	74	Both	AS Spectrum Treatment Group:40;		China
8	NCT04839315 (ClinicalTrials.gov)	February 15, 2021	5/4/2021	COVID-19 Vaccination in Rheumatic Disease Patients	Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases	Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankyl ...	Biological: mRNA COVD19 vaccine	Mayo Clinic	NULL	Recruiting	18 Years	N/A	All	100	Early Phase 1	United States
9	JPRN-JapicCTI-205414	12/12/2020	18/08/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in subjects with ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Nonradiographic axial spondyloarthritis / Ankylosing spondylitis	Intervention name : UCB4940 INN of the intervention : bimekizumab Dosage And administration of the int ...	UCB Japan Co., Ltd.	NULL	recruiting	18		BOTH	30	Phase 3	Japan, Asia except Japan, North America, Europe
10	EUCTR2019-004163-47-GB (EUCTR)	08/10/2020	05/08/2020	A study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in subjects with ...	A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Bimekizumab Product Code: UCB4940 INN or Proposed INN: BIMEKIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	United States;Spain;Turkey;United Kingdom;France;Czech Republic;Hungary;Belgium;Poland;Bulgaria;Germ ...

First Previous1 2 3 4 5…28Next Last